Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Fen "Eric" Zhang, Ph.D., is a Chinese-born special purpose acquisition company (SPAC) executive and investment professional who currently serves as Chairman and Chief Executive Officer of Columbus Acquisition Corp (NASDAQ: COLA/COLAR), a Cayman Islands-incorporated blank check company headquartered in Singapore. Zhang has led Columbus Acquisition Corp since its formation on January 18, 2024, guiding the company through its initial public offering, which closed on January 24, 2025, raising $60 million through the sale of 6,000,000 units at $10.00 per unit on the Nasdaq Global Market, with A.G.P./Alliance Global Partners serving as sole book-running manager and The Benchmark Company, LLC as co-manager. The SPAC is sponsored by Hercules Capital Management VII Corp and was formed to identify and execute a business combination across any industry or geographic region. In November 2025, Columbus Acquisition Corp entered into a definitive Business Combination Agreement with WISeSat.Space AG, a subsidiary of WISeKey International Holding Ltd, in a reverse merger transaction valued at approximately $260 to $348 million, which would result in the public listing of WISeSat.Space under the name WISeSat.Space Holdings Corp. Zhang resides in China for business purposes and can be reached at eric.zhang@hercules.global.
Beyond Columbus Acquisition Corp, Zhang serves as Chairman and Chief Executive Officer of Eureka Acquisition Corp (EURK), a second SPAC that raised $50 million in its IPO in March 2024 with Maxim Group LLC as bookrunner. He has also been associated with Oak Woods Acquisition Corporation (OAKU), a $50.9 million SPAC that went public in February 2023 with EF Hutton, division of Benchmark Investments, LLC, as bookrunner. Across these three vehicles, Zhang has overseen aggregate capital deployment of approximately $160.9 million. His frequent transaction associates include Kevin McKenzie, M. Anthony Wong, and Lauren Simmons, and he has worked with a range of underwriters including A.G.P./Alliance Global Partners, Maxim Group, and EF Hutton. In the United Kingdom, Zhang was appointed a director of FZANEN LIMITED on August 12, 2025, resigning on March 31, 2026; Companies House records indicate he was born in April 1975, holds Chinese nationality, and resides in China.
Zhang's professional background extends beyond the SPAC arena. He holds a Master's degree in Operations Research from Columbia University and also attended Beijing Normal University. He has over a decade of experience in investment banking and fund management, according to his professional biography. Zhang has served as CEO at CollTech North America, based in California, and as Executive Business Partner to the CEO and Founder at OpenResty Inc., a software company based in San Mateo, California. He has also held a director position at Abalone Bio, where his LinkedIn profile indicates over 18 years of hands-on experience across a broad spectrum of antibody discovery projects, spanning both murine and human platforms. This combination of deep scientific expertise and extensive capital markets experience positions Zhang at the intersection of biotechnology, technology, and financial services.
Zhang's track record in the SPAC space reflects both the opportunities and challenges of the current market environment. While his Eureka Acquisition Corp and Oak Woods Acquisition Corporation vehicles are listed as closed, Columbus Acquisition Corp has faced Nasdaq listing compliance issues, including notifications regarding minimum holder requirements and market value of listed securities falling below the $50 million threshold. The company has received extensions from Nasdaq through November 18, 2026 to regain compliance on these matters. Despite these headwinds, the pending WISeSat.Space business combination represents a significant potential transaction for Zhang's SPAC portfolio, targeting the technology sector with a global geographic focus. Zhang's multi-vehicle SPAC strat
This record is keyed to SEC CIK 0002026975 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 24 institutional-holder rows on these vehicles, under 9 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.